| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | Executive Vice President, Chief People Officer | Common Stock | 45,684 | $61,673 | $1.35 | 30 Oct 2023 | Direct |
| Seres Therapeutics, Inc. | Executive Vice President, Chief People Officer | Restricted Stock Units | 9,417 | $10,170 | $1.08 | 27 Oct 2023 | Direct |
| Seres Therapeutics, Inc. | Executive Vice President, Chief People Officer | Stock Option (Right to Buy) | 95,000 | 03 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | 27 Oct 2023 | 4 | -$3,920 | 4 | Executive Vice President, Chief People Officer | 31 Oct 2023, 21:43 |
| MCRB | Seres Therapeutics, Inc. | 03 Feb 2023 | 2 | $0 | 4 | Executive Vice President, Chief People Officer | 07 Feb 2023, 16:42 |
| MCRB | Seres Therapeutics, Inc. | 05 Jul 2022 | 1 | +$100,000 | 4 | Executive Vice President, Chief People Officer | 06 Jul 2022, 19:25 |
| MCRB | Seres Therapeutics, Inc. | 07 Feb 2022 | 1 | $0 | 4 | Executive Vice President, Chief People Officer | 08 Feb 2022, 20:35 |
| MCRB | Seres Therapeutics, Inc. | 07 Feb 2022 | 0 | $0 | 3 | Executive Vice President, Chief People Officer Exhibit List: Exhibit 24 - Power of Attorney | 08 Feb 2022, 20:30 |